KMS Medisurgi Ltd (KMSMEDI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by KMS Medisurgi Ltd on NSE and BSE, with an AI summary of each filing.
KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 and ....
Intimation · 14 Nov 2026, 5:30 am
KMS Medisurgi Schedules Board Meeting for H1 FY27 Results KMS Medisurgi Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and approve the un-audited financial results along with the limited review report for the half-year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for designated persons and their immediate relatives commenced on 1st Oct'26 and will remain closed until 48 hours post the declaration of the financial results.
Non applicability of report on Corporate Governance
Others (Uncategorized) · 21 Oct 2026, 5:11 pm
KMS Medisurgi Confirms Non-Applicability of Corporate Governance Report for Q2 FY27 KMS Medisurgi Limited notified BSE that compliance with Corporate Governance provisions under Regulation 27(2) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended 30th Sep'26. As an entity listed on the BSE SME Platform, the company qualifies for exemption under Regulation 15(2)(b) of SEBI LODR, thereby relieving it from the requirement to submit quarterly corporate governance reports.
Cessation of Mr. Hardik Rajnikant Bhatt as an Independent Director of the company upon completion of his second term of appointment as an Independent director.
Change in Management · 01 Oct 2026, 5:13 pm
KMS Medisurgi Announces Cessation of Independent Director Hardik Rajnikant Bhatt KMS Medisurgi Limited announced the cessation of Mr. Hardik Rajnikant Bhatt (DIN: 07566870) as an Independent Director of the company, effective from the close of business hours on 30th Sep'26. The departure follows the completion of his second term of appointment in the role. Mr. Bhatt holds no directorships in any other listed companies.
Cessation of Mr. Kamlesh Rajani Chunilal as an Independent Director of the company upon completion of his second term of appointment as an Independent Director
Change in Management · 01 Oct 2026, 5:05 pm
KMS Medisurgi Announces Cessation of Independent Director Kamlesh Rajani Chunilal KMS Medisurgi Limited has disclosed that Independent Director Mr. Kamlesh Rajani Chunilal (DIN: 07588417) has ceased to be a director of the company effective from the close of business hours on 30th Sep'26. The cessation follows the completion of his second consecutive term as an Independent Director, in compliance with SEBI Listing Regulations. He holds no directorships in other listed entities, and no board committee updates were reported.
Disclosure of voting Results of the 28th Annual General meeting along with Consolidated Scrutinizer report.
Annual General Meeting · 30 Sept 2026, 10:28 pm
Summary of proceedings of the 28th AGM of the company.
Annual General Meeting · 30 Sept 2026, 9:27 pm
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Annual Report of KMS Medisurgi Limited for the Financial ....
Others (Uncategorized) · 09 Sept 2026, 12:46 am
Record date for payment of Dividend
Dividend · 05 Sept 2026, 9:29 pm
KMS Medisurgi Declares Dividend and Sets Record Date for FY26 KMS Medisurgi Limited has declared a dividend of Rs. 0.05 (0.5%) per equity share for the financial year ended 31st Mar'26. The company has fixed Wednesday, 23rd Sep'26, as the record date to determine eligible shareholders. Additionally, the Register of Members and Share Transfer books will remain closed from Thursday, 24th Sep'26 to Wednesday, 30th Sep'26 (both days inclusive) for dividend payment processing.
Board Recommended final dividend of Rs. 0.05 (0.5%) per equity shares for the year ended 31st March, 2026 subject to approval of shareholders.
Dividend · 05 Sept 2026, 9:22 pm
KMS Medisurgi Recommends 0.5% Final Dividend for FY26 KMS Medisurgi Limited’s Board has recommended a final dividend of Rs. 0.05 (0.5%) per equity share for the financial year ended 31st Mar'26, subject to shareholder approval. The company fixed 23rd Sep'26 as the record date to determine eligible members. The Register of Members and Share Transfer Books will remain closed from 24th Sep'26 to 30th Sep'26. Additionally, the 28th Annual General Meeting is scheduled for 30th Sep'26, with M/s. Naveen Karn & Associates appointed as the scrutinizer for the e-voting process.
Board of Directors recommended Final Dividend of Rs. 0.05 (0.5%) per equity shares for the year ended 31st March, 2026 subject to approval of shareholders.
Dividend · 05 Sept 2026, 9:18 pm
KMS Medisurgi Recommends Final Dividend and Schedules 28th AGM KMS Medisurgi's Board of Directors recommended a final dividend of Rs. 0.05 (0.5%) per equity share for FY25-26, subject to shareholder approval. The company fixed 23rd Sep'26 as the record date to determine eligible shareholders for the dividend payout. Additionally, the 28th Annual General Meeting is scheduled for 30th Sep'26, with the Register of Members and Share Transfer Books closing from 24th Sep'26 to 30th Sep'26. M/s. Naveen Karn & Associates has been appointed as the scrutinizer for the e-voting process.
Notice of 28th Annual General Meeting
Annual General Meeting · 05 Sept 2026, 9:11 pm
Outcome of Board meeting held on Saturday, 05th September, 2026
Outcome · 05 Sept 2026, 9:04 pm
KMS Medisurgi Recommends Final Dividend and Schedules 28th AGM KMS Medisurgi Limited’s Board recommended a final dividend of Rs 0.05 (0.5%) per equity share for FY26, subject to shareholder approval at its 28th Annual General Meeting scheduled for 30th Sep'26. The board fixed 23rd Sep'26 as the record date to determine member eligibility for the dividend payout. Additionally, the Register of Members and Share Transfer Books will remain closed from 24th Sep'26 to 30th Sep'26. M/s Naveen Karn & Associates has been appointed as the scrutinizer for the e-voting process.
KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 ,inter alia, to consider and approve Intimation of Board Meeting scheduled ....
Intimation · 27 Aug 2026, 10:09 pm
KMS Medisurgi Board Meeting to Consider FY26 Results and Dividend KMS Medisurgi (Scrip: 540468) has scheduled a Board of Directors meeting on 05th Sep'26. The key agenda is to consider and approve the financial statements for the year ended 31st Mar'26. The board will also consider and recommend a final dividend, if any, for the same period. Other items include approving the Directors' Report and setting the agenda for the 28th Annual General Meeting, including the closure dates for the Register of Members.
Non applicability of report on corporate governance pursuant to regulation 27(2) of the SEBI (Listing obligation and disclosure requirements) Regulation 2015.
Others (Uncategorized) · 21 Jul 2026, 11:47 pm
KMS Medisurgi Exempted From Corporate Governance Reporting for Q1FY27 KMS Medisurgi Limited (BSE: 540468) has informed the exchange on 20-Jul'26 that it is not required to file the corporate governance report for the quarter ended 30-Jun'26. The company claims exemption under Regulation 15(2) of SEBI (LODR) Regulations, 2015. This exemption applies as KMS Medisurgi is listed on the BSE SME Platform, relieving it from compliance with corporate governance provisions specified in Regulation 27(2) for the said period.
Submission of Standalone audited financial results for the year ended 31 March, 2026
Outcome · 30 May 2026, 10:01 pm
KMS Medisurgi Reports FY26 Results with Qualified Audit Opinion KMS Medisurgi's board approved audited standalone results for the year ended 31 Mar'26, which received a qualified audit opinion. The auditors cited two reasons: a departure from AS-15 for post-employment benefits, whose deviation impact is unascertainable, and an inability to comment on the closing stock value of Rs 2.54 crore due to ongoing record reconciliation. For FY26, the company reported revenue from operations of Rs 12.21 crore and a net profit of Rs 24.55 lakhs, down 44.2% YoY from Rs 43.98 lakhs in FY25.
Submission of Standalone Audited financial result for the year ended 31.03.2026.
Financial Result · 30 May 2026, 9:57 pm
KMS Medisurgi Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 559 (-8.7% YoY | -15.5% QoQ) ■ EBITDA: 39.5 (-45.0% YoY | -21.3% QoQ) ■ EBITDA Margin (%): 7.1 (-467 bps YoY | -52 bps QoQ) ■ PAT: 1.4 (-96.1% YoY | -94.0% QoQ) ■ EPS (INR): 0.04 (-96.3% YoY | -94.3% QoQ)
KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve This is to inform you that pursuant ....
Intimation · 30 May 2026, 5:30 am
KMS Medisurgi Board Meeting Scheduled for FY26 Financial Results KMS Medisurgi (BSE: 540468) will hold a Board of Directors meeting on 30th May'26 to consider and approve the standalone audited financial results for the year ended 31st Mar'26. In compliance with insider trading regulations, the trading window for dealing in the company's equity shares has been closed since 01st Apr'26 and will reopen 48 hours after the financial results are communicated to the stock exchange.
Meeting of the Board of Directors of the company will be held on Saturday, May 30, 2026, at 02.00 pm at the registered office of the company.
Intimation · 30 May 2026, 5:30 am
KMS Medisurgi Board Meeting on May 30 to Approve FY26 Results KMS Medisurgi Limited (BSE: 540468) has scheduled a Board of Directors meeting for 2:00 PM on Sat, 30th May'26. The primary agenda is to consider and approve the standalone audited financial results for the financial year ending 31st Mar'26. In accordance with insider trading regulations, the trading window for dealing in the company's equity shares has been closed since 01st Apr'26 and will reopen 48 hours after the financial results are communicated to the stock exchange.
Mr. Pratik Pravin Tarpara has ceased to be an Independent Director of the company w.e.f. 30th September, 2025 upon completion of his tenure.
Change in Management · 08 May 2026, 7:36 pm
KMS Medisurgi Announces Independent Director's Departure KMS Medisurgi announced that Mr. Pratik Pravin Tarpara (DIN: 08689556) will cease to be an Independent Director effective 30th Sep'25. The change follows the completion of his first term. Mr. Tarpara holds no other directorships in listed companies. This event constitutes a routine board composition update with no disclosed conflicts or relationships between directors.
Non applicability of Regulation 24A of SEBI (LODR) Regulation, 2015.
Others (Uncategorized) · 29 Apr 2026, 6:57 pm
KMS Medisurgi Claims Exemption from Secretarial Compliance Report Rule KMS Medisurgi Limited, listed on the BSE SME Platform, has informed exchanges on 29 Apr'26 of the non-applicability of SEBI's Regulation 24A. This exempts the company from submitting the Annual Secretarial Compliance Report. The exemption is claimed under Regulation 15(2), which applies to entities listed on an SME exchange and those with paid-up capital under ₹10 crore and net worth under ₹25 crore as of the last financial year. This significantly reduces the company's compliance and disclosure requirements.
Non applicability of report on CG.
Others (Uncategorized) · 21 Apr 2026, 7:15 pm
KMS Medisurgi Claims Exemption from Corporate Governance Reporting for FY26 KMS Medisurgi Limited (BSE: 540468) informed the exchange on 21 Apr'26 that it is not required to submit a corporate governance report for the year ended 31 Mar'26. The company claims exemption under Regulation 15(2) of SEBI's LODR Regulations, citing its listing on the BSE SME Platform. This regulation exempts certain smaller companies from complying with specific corporate governance provisions, including the requirement under Regulation 27(2) to file a quarterly compliance report on corporate governance.
Non applicability of Disclosure of related party transactions.
Others (Uncategorized) · 21 Apr 2026, 6:54 pm
KMS Medisurgi Claims Exemption from Related Party Transaction Disclosures KMS Medisurgi (BSE: 540468) has informed the exchange on 21-Apr-26 that it is not required to disclose Related Party Transactions for the fiscal year ended 31-Mar-26. The company claims exemption under SEBI's Regulation 15(2), citing its listing on the BSE SME Platform. This regulation exempts certain SME-listed entities from corporate governance provisions, including the disclosure requirements under Regulation 23(9). This notice reduces transparency for investors regarding transactions between the company and its related parties for the specified period.
Non applicability of CG report
Others (Uncategorized) · 14 Jan 2026, 4:55 pm
KMS Medisurgi Claims Exemption from Corporate Governance Reporting KMS Medisurgi Limited (BSE: 540468) informed exchanges on 13 Jan '26 that it is not required to submit a Corporate Governance Report for the quarter ended 31 Dec '25. The company claims exemption under SEBI Regulation 15(2) as it is listed on the BSE SME Platform. This regulation exempts entities listed on SME exchanges from complying with specific corporate governance provisions, including Regulation 27(2), which mandates the report. Consequently, stakeholders will not receive the standard governance disclosures for the period.
Non applicability of related party transaction
Others (Uncategorized) · 14 Nov 2025, 11:10 pm
Submission of Unaudited financial results for the Half year ended September 30, 2025
Outcome · 14 Nov 2025, 11:07 pm